Articles


Aclaris Therapeutics

Aclaris Therapeutics Announces Leadership Shake-up and Strategic Review, Investors Watch Closely

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a biopharmaceutical company specializing in dermatological treatments, has announced significant changes to its leadership and an impending strategic review of its business …

Aclaris Therapeutics Announces Leadership Shake-up and Strategic Review, Investors Watch Closely Read More

InterDigital

InterDigital Inks Patent License Agreement with Samsung, Bolstering its Position in Consumer Electronics

WILMINGTON, DE — InterDigital, Inc. (Nasdaq: IDCC), a heavyweight in the mobile and video technology industry, has announced a new patent licensing agreement with global electronics giant Samsung. This strategic …

InterDigital Inks Patent License Agreement with Samsung, Bolstering its Position in Consumer Electronics Read More